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Invited Commentary 
Laza r  J. Greenf ie ld ,  M.D.  
Department of Surgery, University of Michigan, Ann Arbor, 
Michigan, U.S.A. 
Since its introduction in 1972, the Greenfield filter has been 
inserted in more than 70,000 patients in this country alone and 
has established a record of safety and effectiveness for periods 
of follow-up in excess of 12 years [1]. Therefore, the unusual 
complication of recurrent embolism reported by Richenbacher 
and associates deserves careful consideration. This report 
actually describes 2 cases with complications, the first of which 
is described as filter "thrombosis."  We know on the basis of 
both experimental and clinical observations over prolonged 
periods that the filter is not thrombogenic and remains patent 
with or without anticoagulant administration. Therefore, the 
sudden development of "marked bilateral lower extremity 
swelling" is the expected result of an embolus to the filter 
sufficiently large to produce total caval obstruction. This has 
occurred 3 times in our experience, always within 2 weeks of 
insertion, and resulted in relative hypovolemia requiring fluid 
resuscitation to replace the vascular volume sequestered in the 
lower extremities. Although a significant complication, it com- 
pares favorably with the consequences of a similar volume of 
embolus into the pulmonary vascular bed. The use of lytic 
therapy should be considered under these circumstances to 
restore vena caval patency. 
The second case report describes a patient with preoperative 
pulmonary embolism of an unknown configuration affecting 
perfusion of the right upper lobe. The patient developed post- 
operative deep vein thrombosis which required increasing lev- 
els of heparin for control and then the patient died suddenly on 
the fourth postoperative day with evidence at autopsy of 
thrombi in both pulmonary arteries and within the caval filter 
with cephalad propagation. This complication is, fortunately, 
rare, and although recurrent embolism was seen in 4% of our 
469 patients over a 12-year period of follow-up, none was fatal. 
The circumstances which favor this thrombotic progression 
seem to be related to poor control o fa  hypercoagulable state. In 
general, a dose of 5,000 u heparin IV in a patient with active 
thrombosis as used by the authors is inadequate because of the 
elevated levels of circulating thrombin. A dose of 150 u/Kg 
would be preferable and more effective in achieving therapeutic 
control. Unfortunately, this is no guarantee that an embolism 
will be prevented since we have demonstrated that the presence 
of a proximal floating tail on iliofemoral venous thrombi is 
associated with a 10 times greater likelihood of embolism than 
when the thrombus is attached circumferentially [2]. The vol- 
ume of embolus that was trapped in the filter in this case was 
also sizeable, as demonstrated in Fig. 1, and appeared to 
occlude the cava. Even if there were still some flow in the cava, 
the degree of stagnation would be another factor favoring 
thrombus propagation. 
In their review of other reported cases of recurrent embolism, 
the authors perpetuate the error of ascribing misplacement of 
the filter into an iliac vein as caudal migration (patient no. 6). As 
indicated in a previous editorial [3], in order for the filter to 
migrate into the smaller iliac vein, it would have to detach itself 
from the caval wall and refold itself into the smaller diameter of 
the iliac vein, a talent it does not possess. Misplacement into an 
iliac vein obviously fails to protect the patient from emboli 
originating from the opposite side. In another unusual case of 
recurrent embolism (patient no. 3), the authors in that report 
demonstrated apparent lack of contact of the filter with the 
anterior wall of the vena cava and postulated that the entrapped 
embolus had caused retraction of the limbs and disengagement 
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of the hooks from the vena cava. An alternative explanation 
that has been observed on more than one occasion is that a 
thrombus formed within the carrier at the time of insertion, 
tethering the limbs of the filter and resulting in nonuniform 
fixation at the time of insertion. This complication is prevent- 
able by irrigation of the carrier system with dilute heparin 
during insertion. Although we have little information regarding 
all the effects of  thrombus capture on the filter once it is 
inserted, the only limb contracture after insertion has been 
when the filter is totally obstructed by a massive embolus and 
the cava contracts by fibrotic organization. 
The algorithm proposed for the follow-up of  patients with 
Greenfield filters (Fig. 2) is based on symptoms and perfusion 
lung scans which are known to be of very poor specificity for 
thromboembolism [4]. It also relies on signs and symptoms for 
detecting recurrent  venous thrombosis or a change in filter 
diameter on the radiograph which will only occur if the cava is 
thrombosed as described above. Our preference is to use 
noninvasive duplex examinations on an annual basis which 
provide/3-mode imaging of  the vena cava and filter as well as 
Doppler flow studies of  the appropriate veins including the site 
of insertion. We also use abdominal radiographs to monitor the 
position of the filter and will perform a vena cavagram for any 
suggestion of thrombus proximal to the filter or any signs of 
recurrent embolism. The magnetic resonance imaging study has 
also been utilized to demonstrate intracaval thrombus. The use 
of thrombolytic therapy for thrombi attached to the filter may 
be appropriate unless there is a long tail of  thrombus that is 
susceptible to detachment; in which case, a second filter should 
be placed above the level of the renal veins as suggested by the 
authors. For  the patient with an uncontrolled upper extremity 
source of thromboembolism, it may be necessary to insert a 
filter into the superior vena cava as we have reported [5]. It 
seems clear that many of  these patients will continue to 
manifest an aggressive thrombotic disorder, often in spite of 
anticoagulation, and therefore they all deserve very careful 
long-term follow-up care. 
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